Clinical Trial: A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepatocellular Carcinoma

U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07535840) titled 'A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectabl... Read More

Clinical Trial: GALLVIA Trial: EUS-Guided vs Transpapillary Gallbladder Drainage for Acute Calculous Cholecystitis

U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07536191) titled 'GALLVIA Trial: EUS-Guided vs Transpapillary Gallbladder Drainage for Acute Calculous Chole... Read More

Swayambhu Netflix OTT: నిఖిల్ స్వయంభుకు నెట్‌ఫ్లిక్స్ ఓటీటీ క్రేజీ డీల్ ఆఫర్.. టాలీవుడ్‌లో సరికొత్త ట్రెండ్!

భారతదేశం, ఏప్రిల్ 18 -- Swayambhu Netflix OTT: కార్తికేయ 2 సినిమాతో పాన్ ఇండియా స్థాయిలో గుర్తింపు తెచ్చుకున్న నిఖిల్ సిద్ధార్థ.. ఇప్పుడు 'స్వయంభు' (Swayambhu) అనే భారీ బడ్జెట్ సినిమాతో ప్రేక్షకుల ముం... Read More

Juju icon Y.K. Ajao is dead

Nigeria, April 18 -- Popular Nigerian juju musician Yekini Ajao is dead. His death was announced in a statement posted on Shina Peters' Instagram page on Friday night. The 67-year-old described the ... Read More

Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, April 18 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 18 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 18 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 18 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, April 18 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More

• ««
• «
• 17297
• 17298
• 17299
• 17300
• 17301
• 17302
• 17303
• 17304
• 17305
• 17306
• »
• »»